Prosecution Insights
Prosecution Insights
Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Exokeryx Inc. currently has 1 pending office action in the Chemistry & Materials technology area. This action is handled by 1 distinct examiner, QIAN, SHIZHI, in 1 distinct art unit. QIAN, SHIZHI is also the busiest examiner with 1 pending office action, which is the only active matter for the company at this time.
The presence of 1 pending office action indicates a singular focus for the company's current prosecution efforts. Having 1 distinct examiner, QIAN, SHIZHI, means that the legal strategy is focused on a single point of contact at the patent office. This 1 pending office action is located within 1 distinct art unit, suggesting that the technology is classified within a single specialized examination group.
For a practitioner, the 1 pending office action requires a targeted approach to address the specific concerns of 1 distinct examiner. Since QIAN, SHIZHI is the busiest examiner with 1 pending action, there are no other competing cases to manage for this portfolio. The focus remains entirely on resolving the 1 pending office action within the 1 distinct art unit assigned to the case.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| QIAN, SHIZHI | 1 | 62.0% | +46.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18339511 | Systems and Methods for Digital, Multiplexed, Extracellular Vesicle-Derived Biomarker Diagnostic Lab-on-a-Chip | QIAN, SHIZHI | 56d |
| Art Unit | Apps |
|---|---|
| 1795 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18339511 | Systems and Methods for Digital, Multiplexed, Extracellular Vesicle-Derived Biomarker Diagnostic Lab-on-a-Chip | QIAN, SHIZHI | 1795 | §112 | Final Rejection | 56d | Pending | Jun 22, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialExokeryx Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Shizhi Qian has the most, with 1 of Exokeryx Inc.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.